These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 702700)

  • 41. [Peritoneovenous shunt in surgical therapy of ascites].
    Feussner H; Weiser HF
    Leber Magen Darm; 1986 Jul; 16(4):230-7. PubMed ID: 3747701
    [No Abstract]   [Full Text] [Related]  

  • 42. [Coagulant and procoagulant factors in ascitic fluid--about etiology DIC induced by ascitic fluid infusion (author's transl)].
    Ojiro M
    Igaku Kenkyu; 1981 Oct; 51(4):177-85. PubMed ID: 7331734
    [No Abstract]   [Full Text] [Related]  

  • 43. Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation.
    Büller HR; ten Cate JW
    Thromb Haemost; 1983 Apr; 49(2):128-31. PubMed ID: 6868009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bleeding complications of the LeVeen shunt].
    Friedrichs O
    Med Welt; 1983 Jul; 34(27):754-5. PubMed ID: 6888245
    [No Abstract]   [Full Text] [Related]  

  • 45. Coagulopathy following peritoneovenous shunting.
    Schwartz ML; Swaim WR; Vogel SB
    Surgery; 1979 Jun; 85(6):671-6. PubMed ID: 377537
    [No Abstract]   [Full Text] [Related]  

  • 46. Prevention of coagulopathy after placement of peritoneovenous shunt with replacement of ascitic fluid by normal saline solution.
    Biagini JR; Belghiti J; Fekete F
    Surg Gynecol Obstet; 1986 Oct; 163(4):315-8. PubMed ID: 3764636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapy of refractory ascites. Surgical technic and monitoring of the peritoneovenous shunt].
    Torre GC
    Minerva Med; 1987 May; 78(10):697-704. PubMed ID: 3587719
    [No Abstract]   [Full Text] [Related]  

  • 48. Complications associated with the implantation of peritoneo-venous valves and possibilities of prevention.
    Vincze K
    Acta Chir Hung; 1994; 34(3-4):323-32. PubMed ID: 7618386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Surgical solution to intractable ascites in 3 series of patients treated with continuous peritoneo-venous shunting].
    Giordani M
    Minerva Chir; 1989 Feb; 44(3):457-61. PubMed ID: 2654717
    [No Abstract]   [Full Text] [Related]  

  • 50. Peritoneovenous shunts in the management of malignant ascites.
    Souter RG; Tarin D; Kettlewell MG
    Br J Surg; 1983 Aug; 70(8):478-81. PubMed ID: 6871638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Five cases of disseminated intravascular coagulation after peritoneojugular shunt by Le Veen valve].
    Jobard J; Marcillon M; Guillot F; Maestracci P
    Ann Anesthesiol Fr; 1980; 21(5):531-4. PubMed ID: 6109502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coagulopathy associated with peritoneovenous shunting.
    Tawes RL; Sydorak GR; Kennedy PA; Brown WH; Scribner RG; Beare JP; Harris EJ
    Am J Surg; 1981 Jul; 142(1):51-5. PubMed ID: 7258515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemorrhage from esophageal varices after placement of the LeVeen shunt.
    Markey W; Payne JA; Straus A
    Gastroenterology; 1979 Aug; 77(2):341-3. PubMed ID: 312748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgical treatment of ascites.
    LeVeen HH; Brown T; d'Ovidio NG
    Adv Surg; 1980; 14():107-50. PubMed ID: 7008545
    [No Abstract]   [Full Text] [Related]  

  • 55. [Disseminated intravascular coagulation caused by re-infusion of ascitic fluid. Correlations between pro-aggregant and pro-coagulant factors of the ascitic fluid].
    Armani U; Testa R; Piana A; Dellepiane F; Bonadonna R
    Arch Maragliano Patol Clin; 1979; 35():53-5. PubMed ID: 263696
    [No Abstract]   [Full Text] [Related]  

  • 56. Peritoneovenous shunt in the management of ascites and the hepatorenal syndrome.
    Epstein M
    Gastroenterology; 1982 Apr; 82(4):790-9. PubMed ID: 7037522
    [No Abstract]   [Full Text] [Related]  

  • 57. Failure of ascitic fluid replacement for prevention of coagulopathy post peritoneovenous shunt. Case report.
    Gagner M; Franco D
    Acta Chir Scand; 1990 Apr; 156(4):337-40. PubMed ID: 2349854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers.
    Levi M
    Thromb Res; 2018 Apr; 164 Suppl 1():S77-S81. PubMed ID: 29703488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LeVeen shunts in patients with intractable malignant ascites.
    Kudsk K; Fabian TC; Minton JP
    J Surg Oncol; 1980; 13(1):61-6. PubMed ID: 6153229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.